Search
+
    SEARCHED FOR:

    ENTERO IPO NEWS

    Shares worth $21 billion to enter market in 4 months as IPO lock-in period expires for 66 companies

    66 companies are set to see the lock-in period for pre-listing shareholders lifted between March 4 and June 29. This amounts to $21.1 billion in value terms. The value pertains to the total lock-up opening shares, but not all the shares may be sold, as a sizable portion is also held by promoters and group entities

    Entero Healthcare shares to list on Friday. What GMP signals ahead of D-St debut

    In the unlisted market, the company's shares are trading with a marginal premium of Rs 2, which indicates a flat or even a discounted debut at the bourses. The IPO comprised a fresh equity issue of Rs 1,000 crore and an offer for sale of up to 47.69 lakh shares.

    Entero Healthcare IPO fully subscribed on final day. Check subscription, GMP and other details

    Entero Healthcare IPO comprises a fresh equity issue of Rs 1,000 crore and an OFS of up to 47.69 lakh shares. Prabhat Agrawal, Prem Sethi, Orbimed Asia Iii Mauritius, Chethan MP, and Deepesh T Gala, among others, will offload shares under the OFS. The shares are trading with a marginal premium of Rs 10 in the grey market.

    Entero Healthcare IPO sees tepid response. Check subscription, GMP, and other details

    Entero Healthcare IPO price band has been fixed from Rs 1,195-1258 per equity share. Bids can be made for a minimum of 11 shares and in multiples thereafter. the shares are trading with a marginal premium of Rs 5 in the grey market.

    Last leg of Q3 earnings among 5 factors to dictate Nifty mood this week

    ​Led by the downside in private bank stocks, Nifty slipped 0.33% lower and broadly consolidated in the 21,600–22,000 range during the week. PSU banks outshined with SBI leading with a 12% upside in just five days.

    Massive growth opportunities for healthcare industry in India: Entero Healthcare MD

    “Our business model is very simple. We are one of the largest distributors of healthcare products in this country. Basically, we buy from 1900 different companies today and supply to around eighty-one-and-a-half thousand retail pharmacies and three-and-a-half thousand hospitals.”

    The Economic Times
    BACK TO TOP